Variable | β | χ2 | P | OR | 95% CI |
---|
Age | − 0.121 | 5.553 | 0.045 | 0.886 | 0.794–0.988 |
BMI | − 0.129 | 2.811 | 0.048 | 0.879 | 0.781–0.989 |
HADS-A | 0.213 | 17.358 |  < 0.001 | 1.238 | 1.097–1.396 |
HADS-D | 0.163 | 16.602 |  < 0.001 | 1.178 | 1.034–1.340 |
mMRC | 0.260 | 24.356 |  < 0.001 | 1.297 | 1.274–1.320 |
SGRQ | 0.487 | 30.001 |  < 0.001 | 1.627 | 1.401–1.890 |
ACCI | 0.172 | 20.131 |  < 0.001 | 1.165 | 1.051–1.280 |
GOLD grade | 0.259 | 20.035 |  < 0.001 | 1.296 | 1.256–1.337 |
- Alexithymia (TAS-20 > 60) is considered as a dependent variable and sex, age, BMI, smoking, drinking, duration of disease, FEV1% expected value, mMRC scores, HADS-A scores, HADS-D scores, SGRQ scores, and ACCI scores were independent variables. BMI, body mass index; FEV1, forced expiratory volume in 1 s; HADS-A, Hospital Anxiety and Depression Scale for anxiety; HADS-D, Hospital Anxiety and Depression Scale for depression; mMRC, Modified British Medical Research Council; SGRQ, St. George's respiratory questionnaire; ACCI age-adjusted Charlson comorbidity index; GOLD, Global Initiative for Chronic Obstructive Lung Disease